This ICR is
approved per CMS's 10/15/08 memo and revised form. CMS shall ensure
that the Spanish-language version is similarly revised before its
issuance.
Inventory as of this Action
Requested
Previously Approved
10/31/2011
36 Months From Approved
11/30/2008
290,344
0
1,056,000
145,172
0
528,000
0
0
53,000
Pursuant to 42 CFR 423.568(c) and (d),
if a Part D plan denies drug coverage it must give the enrollee
written notice of the adverse coverage determination. The form and
content of the written notice must comport with specific
requirements.
Statute at
Large: 18
Stat. 1860 Name of Statute: null
Statute at Large: 18
Stat. 1852 Name of Statute: null
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.